RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $871M (100.0% shares, 0.0% debt)

Holdings (22)

ASND ASCENDIS PHARMA A S 17.8%
Value $155M Shares 5,580,690 Share Price $27.76 Est. Cost/Share $17.96 Unrealized @ Report Date —
WVE WAVE LIFE SCIENCES LTD 15.1%
Value $132M Shares 7,088,651 Share Price $18.60 * Est. Cost/Share $15.68 Unrealized @ Report Date +37.4%
— AVEXIS INC 12.4%
Value $108M Shares 1,310,046 Share Price $82.16 Est. Cost/Share $31.86 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS INC 7.2%
Value $62.58M Shares 13,633,220 Share Price $4.59 Est. Cost/Share $6.18 Unrealized @ Report Date —
— BIOHAVEN PHARMACTL HLDG CO LTD 7.0%
Value $61.21M Shares 2,448,350 Share Price $25.00 Est. Cost/Share $25.00 Unrealized @ Report Date —
— G1 THERAPEUTICS INC 5.4%
Value $46.81M Shares 2,684,244 Share Price $17.44 Est. Cost/Share $17.44 Unrealized @ Report Date —
— IGNYTA INC 4.8%
Value $41.58M Shares 4,016,990 Share Price $10.35 Est. Cost/Share $9.90 Unrealized @ Report Date —
ESPR ESPERION THERAPEUTICS INC 3.9%
Value $33.85M Shares 731,531 Share Price $46.28 * Est. Cost/Share $23.41 Unrealized @ Report Date +57.1%
— MYOVANT SCIENCES LTD 3.8%
Value $32.85M Shares 2,807,550 Share Price $11.70 Est. Cost/Share $12.11 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 3.3%
Value $28.7M Shares 5,162,242 Share Price $5.56 * Est. Cost/Share $8.20 Unrealized @ Report Date -25.7%
— RA PHARMACEUTICALS INC 2.9%
Value $25.33M Shares 1,351,808 Share Price $18.74 Est. Cost/Share $15.19 Unrealized @ Report Date —
— RADIUS HEALTH INC 2.6%
Value $22.49M Shares 497,157 Share Price $45.23 Est. Cost/Share $45.23 Unrealized @ Report Date —
— ZOGENIX INC 2.5%
Value $21.38M Shares 1,474,688 Share Price $14.50 Est. Cost/Share $13.32 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 2.3%
Value $19.64M Shares 1,396,071 Share Price $14.07 Est. Cost/Share $13.67 Unrealized @ Report Date —
— AVEO PHARMACEUTICALS INC 2.1%
Value $18.73M Shares 8,435,584 Share Price $2.22 Est. Cost/Share $2.22 Unrealized @ Report Date —
— ACORDA THERAPEUTICS INC 2.0%
Value $17.73M Shares 900,259 Share Price $19.70 Est. Cost/Share $20.41 Unrealized @ Report Date —
AKBA AKEBIA THERAPEUTICS INC 1.4%
Value $12.02M Shares 836,337 Share Price $14.37 * Est. Cost/Share $12.68 Unrealized @ Report Date 0.0%
SGMO SANGAMO THERAPEUTICS INC 1.3%
Value $11M Shares 1,250,000 Share Price $8.80 * Est. Cost/Share $6.42 Unrealized @ Report Date 0.0%
— DICERNA PHARMACEUTICALS INC 0.9%
Value $7.699M Shares 2,428,571 Share Price $3.17 Est. Cost/Share $28.25 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.8%
Value $7.035M Shares 700,000 Share Price $10.05 * Est. Cost/Share $10.06 Unrealized @ Report Date +11.3%
KALV KALVISTA PHARMACEUTICALS INC 0.5%
Value $4.35M Shares 591,070 Share Price $7.36 Est. Cost/Share $7.37 Unrealized @ Report Date -0.3%
— PROTEON THERAPEUTICS INC 0.2%
Value $2.04M Shares 1,337,462 Share Price $1.53 Est. Cost/Share $1.53 Unrealized @ Report Date —